Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck

To determine the effect of treatment time‐related factors on outcome in patients treated with surgery and postoperative radiation therapy (RT) for locally advanced squamous cell carcinoma of head and neck (SCCHN)

[1]  H. Withers,et al.  Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.) , 2000, International journal of radiation oncology, biology, physics.

[2]  K. Ang,et al.  Precisely defining high‐risk operable head and neck tumors based on rtog #85‐03 and #88‐24: Targets for postoperative radiochemotherapy? , 1998, Head & neck.

[3]  A. Huang,et al.  Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. , 1998, The New England journal of medicine.

[4]  J. Cooper,et al.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  D. Klotch,et al.  Postoperative accelerated radiotherapy in high‐risk squamous cell carcinoma of the head and neck: Long‐term results of a prospective trial , 1998, Head & neck.

[6]  L. Peters.  The efficacy of postoperative radiotherapy for advanced head and neck cancer: quality of the evidence. , 1998, International journal of radiation oncology, biology, physics.

[7]  K. Olsen,et al.  Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis. , 1998, International journal of radiation oncology, biology, physics.

[8]  J. Hendry,et al.  Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. , 1998, International journal of radiation oncology, biology, physics.

[9]  H. Withers,et al.  Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factor. , 1997, International journal of radiation oncology, biology, physics.

[10]  S. Stringer,et al.  An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. , 1997, International journal of radiation oncology, biology, physics.

[11]  E. Cohen-Jonathan,et al.  Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. , 1996, International journal of radiation oncology, biology, physics.

[12]  L. Collette,et al.  Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. , 1996, Journal of the National Cancer Institute.

[13]  A. Rijnders,et al.  Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer? , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  S. Bentzen.  Radiobiological considerations in the design of clinical trials. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  A S Garden,et al.  Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. , 1993, International journal of radiation oncology, biology, physics.

[16]  J H Hendry,et al.  Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  J. Cooper,et al.  Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. , 1992, The New England journal of medicine.

[18]  L. Peters,et al.  Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract , 1992, Head & neck.

[19]  W. Panje,et al.  Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  E. Strong,et al.  Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer , 1990, Journal of surgical oncology.

[21]  W. Mendenhall,et al.  Split-course versus continuous-course irradiation in the postoperative setting for squamous cell carcinoma of the head and neck. , 1989, International journal of radiation oncology, biology, physics.

[22]  R. Makuch,et al.  Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program. , 1986, Cancer.

[23]  R. Million,et al.  Management of Head and Neck Cancer: A Multidisciplinary Approach , 1984 .

[24]  B. Vikram,et al.  Importance of the time interval between surgery and postoperative radiation therapy in the combined management of head & neck cancer. , 1979, International journal of radiation oncology, biology, physics.

[25]  I. Kalnins,et al.  Squamous cell carcinoma of the pyriform sinus. , 1978, Head & neck surgery.

[26]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[27]  A. Garden,et al.  A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. , 2000, International journal of radiation oncology, biology, physics.

[28]  G. Calais,et al.  Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. , 1999, Journal of the National Cancer Institute.

[29]  A. Garden,et al.  108Overall time factor in postoperative radiation: Results of a prospective randomized trial , 1996 .

[30]  D. Rosenthal,et al.  A review of neoadjuvant chemotherapy for head and neck cancer: partially shrunken tumors may be both leaner and meaner. , 1994, International journal of radiation oncology, biology, physics.

[31]  J. Fowler,et al.  Effect of overall time and dose on the response of glottic carcinoma of the larynx to radiotherapy. , 1994, European journal of cancer.

[32]  J. Jacobs,et al.  Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. , 1992, International journal of radiation oncology, biology, physics.

[33]  J. M. Taylor,et al.  The hazard of accelerated tumor clonogen repopulation during radiotherapy. , 1988, Acta oncologica.